Showing results (331-340 of 378) with videos related to
Sort By:
Pageof 38
European Journal of Nuclear Medicine and Molecular Imaging|July 15, 2011
Evolving role of FDG PET imaging in assessing joint disorders: a systematic reviewKathleen Carey, Babak Saboury, Sandip Basu, et al.Hellenic Journal of Nuclear Medicine|October 30, 2012
Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changesAnar Aliyev, Babak Saboury, Thomas C Kwee, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2007
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteriesGonca G Bural, Drew A Torigian, Wichana Chamroonrat, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2020
Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive diseaseRahul V Parghane, Vikas Ostwal, Anant Ramaswamy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2021
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant 177Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine TumorsRahul V Parghane, Manish Bhandare, Vikram Chaudhari, et al.Nuclear Medicine Communications|July 8, 2024
Internal dosimetry and biodistribution of indigenously prepared 177 Lu-DOTA-rituximab in lymphoma and other hematological malignancies treated with rituximabYeshwanth Edamadaka, Rahul V Parghane, Sudeep Sahu, et al.Advanced Healthcare Materials|June 30, 2015
Fabrication of 3D Scaffolds with Precisely Controlled Substrate Modulus and Pore Size by Templated-Fused Deposition Modeling to Direct Osteogenic DifferentiationRuijing Guo, Sichang Lu, Jonathan M Page, et al.Cancer Biotherapy & Radiopharmaceuticals|May 8, 2020
Examining Absorbed Doses of Indigenously Developed 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand TherapyKamaldeep, Gaurav Wanage, Sudeep Kumar Sahu, et al.Molecular Imaging and Biology|October 7, 2009
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel conceptGonca G Bural, Drew A Torigian, Anne Burke, et al.Breast Cancer Research and Treatment|January 20, 2009
A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancerAndrea L Cheville, Indra Das, Shyam Srinivas, et al.Pageof 38